{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:42:17Z","timestamp":1792658537402,"version":"4.5.0"},"reference-count":198,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.jaut.2016.02.003","type":"journal-article","created":{"date-parts":[[2016,2,14]],"date-time":"2016-02-14T16:44:17Z","timestamp":1455468257000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Clinical and pathologic considerations of the qualitative and quantitative aspects of lupus nephritogenic autoantibodies: A comprehensive review"],"prefix":"10.1016","volume":"69","author":[{"given":"Mariele","family":"Gatto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Iaccarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ghirardello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Punzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Doria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2016.02.003_bib1","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.amjmed.2005.11.034","article-title":"Long-term prognosis and causes of death in systemic lupus erythematosus","volume":"119","author":"Doria","year":"2006","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jaut.2016.02.003_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1586\/1744666X.2015.990883","article-title":"The multifaceted aspects of refractory lupus nephritis","volume":"11","author":"Moroni","year":"2015","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","article-title":"The frequency and outcome of lupus nephritis: results from an international inception cohort study","volume":"55","author":"Hanly","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2016.02.003_bib4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/acr.20397","article-title":"Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide","volume":"63","author":"Dall\u2019Era","year":"2011","journal-title":"Arthritis Care Res. Hob."},{"key":"10.1016\/j.jaut.2016.02.003_bib5","first-page":"187","article-title":"Biomarker discovery in human SLE nephritis","volume":"65","author":"Rovin","year":"2007","journal-title":"Bull. NYU Hosp. Jt. Dis."},{"key":"10.1016\/j.jaut.2016.02.003_bib6","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/ndt\/gfv107","article-title":"Con: Biomarkers in glomerular diseases: putting the cart before the wheel?","volume":"30","author":"De Vriese","year":"2015","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.jaut.2016.02.003_bib7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrrheum.2015.151","article-title":"Anti-DNA antibodies. quintessential biomarkers of SLE","volume":"12","author":"Pisetsky","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2016.02.003_bib8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/ard.62.3.272","article-title":"Antinucleosome antibodies in the diagnosis of systemic lupus erythematosus","volume":"62","author":"Cairns","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.02.003_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/ar2070","article-title":"Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis","volume":"8","author":"Becker-Merok","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2016.02.003_bib10","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1681\/ASN.2013090987","article-title":"Glomerular autoimmune multicomponents of human lupus nephritis in\u00a0vivo: \u03b1-enolase and annexin AI","volume":"25","author":"Bruschi","year":"2013","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.jaut.2016.02.003_bib11","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1681\/ASN.2014050493","article-title":"Glomerular autoimmune multicomponents of human lupus nephritis in\u00a0vivo (2): planted antigens","volume":"26","author":"Bruschi","year":"2015","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.jaut.2016.02.003_bib12","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.autrev.2015.04.004","article-title":"Multi-antibody composition in lupus nephritis: isotype and antigen specificity make the difference","author":"Bonanni","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2016.02.003_bib13","first-page":"10","article-title":"Novel autoantigens associated with lupus nephritis","volume":"22","author":"Onishi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2016.02.003_bib14","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1177\/0961203311411597","article-title":"Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers","volume":"20","author":"Akhter","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.02.003_bib15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.molimm.2015.05.010","article-title":"C1q, antibodies and anti-C1q autoantibodies","volume":"68","author":"Beurskens","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/rheumatology\/keu326","article-title":"Anti-nucleosome antibodies outperform traditional biomarkers as longitudinal indicators of disease activity in systemic lupus erythematosus","volume":"54","author":"Li","year":"2015","journal-title":"Rheumatol. Oxf."},{"key":"10.1016\/j.jaut.2016.02.003_bib17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-3083.2012.02728.x","article-title":"Antinuclear antibodies in rheumatic disease: a proposal for a function-based classification","volume":"76","author":"Pisetsky","year":"2012","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/0961203308090030","article-title":"Pathogenic anti-nucleosome antibodies","volume":"17","author":"Muller","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.02.003_bib19","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.02.003_bib20","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nrrheum.2015.69","article-title":"The anti-DNA antibody: origin and impact, dogmas and controversies","volume":"11","author":"Rekvig","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2016.02.003_bib21","first-page":"106904","article-title":"The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy","volume":"2015","author":"Moroni","year":"2015","journal-title":"J.\u00a0Immunol. Res."},{"key":"10.1016\/j.jaut.2016.02.003_bib22","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.trsl.2010.07.009","article-title":"Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus","volume":"156","author":"Mok","year":"2010","journal-title":"Transl. Res."},{"key":"10.1016\/j.jaut.2016.02.003_bib23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1191\/0961203306lu2308oa","article-title":"Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis","volume":"15","author":"Jaekell","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.02.003_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.clim.2005.10.009","article-title":"The binding of sera of patients with SLE to bacterial and mammalian DNA","volume":"118","author":"Hamilton","year":"2006","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib25","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1084\/jem.160.4.1102","article-title":"Antigen presentation by hapten-specific B lymphocytes","volume":"160","author":"Rock","year":"1984","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2016.02.003_bib26","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nrrheum.2010.46","article-title":"The role of defective clearance of apoptotic cells in systemic autoimmunity","volume":"6","author":"Mu\u00f1oz","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2016.02.003_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0896-8411(02)00110-5","article-title":"Autoimmunity to nucleosomes related to viral infection: a focus on hapten-carrier complex formation","volume":"20","author":"Van Ghelue","year":"2003","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2016.02.003_bib28","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1002\/1529-0131(199911)42:11<2449::AID-ANR24>3.0.CO;2-P","article-title":"Termination of human T cell tolerance to histones by presentation of histones and polyomavirus T antigen provided that T antigen is complexed with nucleosomes","volume":"42","author":"Andreassen","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.02.003_bib29","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3109\/08916934.2010.536794","article-title":"Regulatory and pathogenic mechanisms of autoantibodies in SLE","volume":"44","author":"Radic","year":"2011","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2016.02.003_bib30","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1191\/096120398678920703","article-title":"Production of pathogenic antibodies: cognate interactions between autoimmune T and B cells","volume":"7","author":"Datta","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.02.003_bib31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.molimm.2004.09.003","article-title":"A\u00a0viral DNA-binding domain elicits anti-DNA antibodies of different specificities","volume":"42","author":"Cerutti","year":"2005","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/0-387-32957-9_9","article-title":"Immunity and autoimmunity induced by polyomaviruses: clinical, experimental and theoretical aspects","volume":"577","author":"Rekvig","year":"2006","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jaut.2016.02.003_bib33","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1172\/JCI119373","article-title":"Experimental expression in mice and spontaneous expression in human SLE of polyomavirus T-antigen. A molecular basis for induction of antibodies to DNA and eukaryotic transcription factors","volume":"99","author":"Rekvig","year":"1997","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.jaut.2016.02.003_bib34","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/art.10254","article-title":"T\u00a0cell autoimmunity to histones and nucleosomes is a latent property of the normal immune system","volume":"46","author":"Andreassen","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.02.003_bib35","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.molimm.2008.09.029","article-title":"IL-2 signalling prevents T cell anergy by inhibiting the expression of anergy-inducing genes","volume":"46","author":"Dure","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib36","doi-asserted-by":"crossref","first-page":"654","DOI":"10.4049\/jimmunol.165.2.654","article-title":"Identification of a minimal T cell epitope recognized by antinucleosome Th cells in the C-terminal region of histone H4","volume":"165","author":"Decker","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib37","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.4049\/jimmunol.1400640","article-title":"Idiotype-specific Th cells support oligoclonal expansion of anti-dsDNA B cells in mice with lupus","volume":"193","author":"Aas-Hanssen","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib38","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.4049\/jimmunol.175.4.2391","article-title":"Systemic autoimmune disease caused by autoreactive B cells that receive chronic help from Ig V region-specific T cells","volume":"175","author":"Munthe","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib39","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1002\/(SICI)1521-4141(199912)29:12<4043::AID-IMMU4043>3.0.CO;2-E","article-title":"Resting small B cells present endogenous immunoglobulin variable-region determinants to idiotype specific CD4+ T cells in\u00a0vivo","volume":"29","author":"Munthe","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1749-6632.2003.tb06035.x","article-title":"Major peptide autoepitopes for nucleosome-centered T and B cell interaction in human and murine lupus","volume":"987","author":"Datta","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2016.02.003_bib41","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3389\/fimmu.2015.00382","article-title":"Systemic lupus erythematosus: molecular mimicry between anti-dsDNA CDR3 idiotype, microbial and self peptides\u2013as antigen for Th cells","volume":"6","author":"Aas-Hanssen","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib42","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/icb.2009.118","article-title":"The cellular mechanism by which complementary Id+ and anti-Id antibodies communicate: T cells integrated into idiotypic regulation","volume":"88","author":"Jacobsen","year":"2010","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.jaut.2016.02.003_bib43","doi-asserted-by":"crossref","first-page":"7476","DOI":"10.4049\/jimmunol.172.12.7476","article-title":"MHC-restricted Ig V region-driven T-B lymphocyte collaboration: B cell receptor ligation facilitates switch to IgG production","volume":"172","author":"Munthe","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib44","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.4049\/jimmunol.1302359","article-title":"Schjetne, Munthe LA, Bogen B. Na\u00efve idiotype specific B and T cells collaborate efficiently in the absence of dendritic cells","volume":"192","author":"Jacobsen","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib45","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/08830189309061709","article-title":"Processing and presentation of idiotypes to MHC-restricted T cells","volume":"10","author":"Bogen","year":"1993","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib46","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cellimm.2006.02.005","article-title":"B\u00a0cells as antigen-presenting cells","volume":"238","author":"Rodriguez-Pinto","year":"2005","journal-title":"Cell Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib47","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3389\/fimmu.2014.00541","article-title":"Frequency patterns of T-cell exposed amino acid motifs in immunoglobulin heavy chain peptides presented by MHCs","volume":"5","author":"Bremel","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.20031234","article-title":"Activation and tolerance in CD4(+) T cells reactive to an immunoglobulin variable region","volume":"200","author":"Snyder","year":"2004","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2016.02.003_bib49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12016-010-8204-4","article-title":"Glomerular Antibodies in Lupus Nephritis","volume":"40","author":"Hanrotel-Saliou","year":"2011","journal-title":"Clin. Rev. Allerg. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib50","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ki.2011.484","article-title":"Anti-DNA autoantibodies initiate experimental lupus nephritis by binding directly to the glomerular basement membrane in mice","volume":"82","author":"Krishnan","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.jaut.2016.02.003_bib51","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/sj.ki.5002126","article-title":"Glomerular binding of anti-dsDNA autoantibodies: the dispute resolved?","volume":"71","author":"van Bavel","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.jaut.2016.02.003_bib52","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3389\/fimmu.2015.00475","article-title":"Mechanisms of kidney injury in lupus nephritis\u2013the role of Anti-dsDNA antibodies","volume":"6","author":"Yung","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib53","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0161-5890(92)90197-6","article-title":"Immunogenicity of Z-DNA depends on the size of polynucleotide presented in complexes with methylated BSA","volume":"29","author":"Edgington","year":"1992","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib54","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3109\/08916934.2014.921811","article-title":"The complex role of DNA, histones and HMBG1 in the pathogenesis of SLE","volume":"47","author":"Pisetsky","year":"2014","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2016.02.003_bib55","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaut.2011.02.001","article-title":"Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus","volume":"36","author":"Ullal","year":"2011","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2016.02.003_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2012.10.004","article-title":"The role of microparticles in the generation of immune complexes in murine lupus","volume":"146","author":"Ullal","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib57","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.4049\/jimmunol.172.11.6692","article-title":"Nucleosomes are exposed at the cells surface in apoptosis","volume":"172","author":"Radic","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib58","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/art.34381","article-title":"Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation","volume":"64","author":"Nielsen","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.02.003_bib59","doi-asserted-by":"crossref","first-page":"267590","DOI":"10.1155\/2015\/267590","article-title":"Microparticles that form immune complexes as modulatory structures in autoimmune responses","volume":"2015","author":"Burbano","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jaut.2016.02.003_bib60","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/art.23626","article-title":"Glomerular targets of nephritogenic autoantibodies in systemic lupus erythematosus","volume":"58","author":"van Bavel","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.02.003_bib61","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/1521-4141(200104)31:4<1221::AID-IMMU1221>3.0.CO;2-P","article-title":"Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry","volume":"31","author":"Mostoslavsky","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib62","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.4049\/jimmunol.175.8.5516","article-title":"Treatment with a laminin-derived peptide suppresses lupus nephritis","volume":"175","author":"Amital","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib63","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1172\/JCI112508","article-title":"Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycosaminoglycan in glomerular basement membranes","volume":"77","author":"Faaber","year":"1986","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.jaut.2016.02.003_bib64","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/art.21622","article-title":"Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis","volume":"54","author":"Kalaaji","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.02.003_bib65","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1136\/ard.2007.070482","article-title":"Nucleosomes possess a high affinity for glomerular laminin and collagen IV and bind nephritogenic antibodies in murine lupus-like nephritis","volume":"66","author":"Mjelle","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.02.003_bib66","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/cm.20007","article-title":"Alpha-actinin revisited: a fresh look at an old player","volume":"58","author":"Otey","year":"2004","journal-title":"Cell Motil. Cytoskelet."},{"key":"10.1016\/j.jaut.2016.02.003_bib67","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.4049\/jimmunol.168.6.3072","article-title":"Alpha-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies","volume":"168","author":"Deocharan","year":"2002","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib68","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.4049\/jimmunol.179.2.1313","article-title":"Alpha-actininimmunization elicits anti-chromatin autoimmunity in non autoimmune mice","volume":"179","author":"Deocharan","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib69","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/art.20103","article-title":"Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis?","volume":"50","author":"Mason","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.02.003_bib70","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/sj.ki.5002133","article-title":"Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis","volume":"71","author":"Kalaaji","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.jaut.2016.02.003_bib71","doi-asserted-by":"crossref","first-page":"R154","DOI":"10.1186\/ar2831","article-title":"Relationship between anti-dsDNA ,anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis:a prospective longitudinal study","volume":"11","author":"Manson","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2016.02.003_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/prca.201400175","article-title":"Autoantibodies targeting glomerular annexin A2 identify patients with proliferative lupus nephritis","author":"Caster","year":"2015","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.jaut.2016.02.003_bib73","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1182\/blood-2008-11-188698","article-title":"Annexin A2 is involved in antiphospholipid antibody-mediate pathogenic effects in vitro and in\u00a0vivo","volume":"114","author":"Romay-Penabad","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2016.02.003_bib74","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.autrev.2011.04.007","article-title":"Anti-annexins autoantibodies: Their role as biomarkers of autoimmune diseases","volume":"10","author":"Iaccarino","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2016.02.003_bib75","doi-asserted-by":"crossref","first-page":"33733","DOI":"10.1074\/jbc.M112.341339","article-title":"Annexin A2 and A5 serve as new ligands for C1q on apoptotic cells","volume":"287","author":"Martin","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jaut.2016.02.003_bib76","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1681\/ASN.2009080805","article-title":"Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis","volume":"21","author":"Yung","year":"2010","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.jaut.2016.02.003_bib77","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1191\/096120301669579565","article-title":"Antinuclear antibodies: to penetrate or not to penetrate, that was the question","volume":"10","author":"Alarcon-Segovia","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.02.003_bib78","first-page":"350","article-title":"Characterization and in\u00a0vivo transfer of nephritogenic autoantibodies directed against dipeptidyl peptidase IV and laminin in experimental lupus nephritis","volume":"63","author":"Bruijn","year":"1990","journal-title":"Lab. Invest"},{"key":"10.1016\/j.jaut.2016.02.003_bib79","doi-asserted-by":"crossref","first-page":"814","DOI":"10.4049\/jimmunol.151.2.814","article-title":"Molecular analysis of spontaneous nephrotropic anti-laminin antibodies in an autoimmune MRL-lpr\/lpr mouse","volume":"151","author":"Foster","year":"1993","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib80","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/08916934.2010.541170","article-title":"Nephritogenic antibodies bind in glomeruli through interaction with exposed chromatin fragments and not with renal cross-reactive antigens","volume":"44","author":"Mjelle","year":"2011","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2016.02.003_bib81","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/art.20862","article-title":"Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential","volume":"52","author":"Zhao","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.02.003_bib82","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2353\/ajpath.2006.051329","article-title":"Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells","volume":"168","author":"Kalaaji","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2016.02.003_bib83","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2353\/ajpath.2008.070563","article-title":"Lupus nephritis: the central role of nucleosomes revealed","volume":"172","author":"Mortensen","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2016.02.003_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1422.001","article-title":"Glomerular targets for autoantibodies in lupus nephritis \u2013 an apoptotic origin","volume":"1108","author":"Zykova","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2016.02.003_bib85","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0896-8411(05)80019-8","article-title":"Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA\/histone complexes","volume":"3","author":"Termaat","year":"1990","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2016.02.003_bib86","first-page":"368274","article-title":"The spectrum of anti-chromatin\/nucleosome autoantibodies: independent and interdependent biomarkers of disease","volume":"2014","author":"Mehra","year":"2014","journal-title":"J.\u00a0Immunol. Res."},{"key":"10.1016\/j.jaut.2016.02.003_bib87","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2119\/molmed.2013.00010","article-title":"Lupus nephritis: enigmas, conflicting models and an emerging concept","volume":"19","author":"Seredkina","year":"2013","journal-title":"Mol. Med."},{"key":"10.1016\/j.jaut.2016.02.003_bib88","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1177\/0961203311417033","article-title":"Antinucleosome antibodies as a potential biomarker for the evaluation of renal pathological activity in patients with proliferative lupus nephritis","volume":"20","author":"Hung","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.02.003_bib89","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1681\/ASN.2008010112","article-title":"Nephritogenic potential of anti-DNA antibodies against necrotic nucleosomes","volume":"20","author":"Mortensen","year":"2009","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.jaut.2016.02.003_bib90","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/cei.12417","article-title":"The effect of cell death in the initiation of lupus nephritis","volume":"179","author":"Fenton","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib91","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.molimm.2010.08.003","article-title":"Lupus-derived monoclonal autoantibodies against apoptotic chromatin recognize acetylated conformational epitopes","volume":"48","author":"van Bavel","year":"2010","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib92","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/art.38365","article-title":"Antinucleosome antibodies","volume":"66","author":"Rekvig","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2016.02.003_bib93","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1749-6632.2003.tb06035.x","article-title":"Major peptide autoepitopes for nucleosome-centered T and B cell interaction in human and murine lupus","volume":"987","author":"Datta","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2016.02.003_bib94","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.4049\/jimmunol.168.5.2530","article-title":"Naturally processed chromatin peptides reveal a major autoepitope that primes pathogenic T and B cells of lupus","volume":"168","author":"Kaliyaperumal","year":"2002","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib95","doi-asserted-by":"crossref","first-page":"J178","DOI":"10.1016\/j.jaut.2009.11.013","article-title":"Nucleic acid-associated autoantigens: pathogenic involvement and therapeutic potential","volume":"34","author":"Hoffmann","year":"2010","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2016.02.003_bib96","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.molimm.2009.08.009","article-title":"Apoptosis-associated acetylation on histone H2B is an epitope for lupus autoantibodies","volume":"47","author":"van Bavel","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib97","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/ard.2010.129320","article-title":"Apoptosis-induced histone H3 methylation is targeted by autoantibodies in systemic lupus erythematosus","volume":"7","author":"van Bavel","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.02.003_bib98","doi-asserted-by":"crossref","first-page":"e1370","DOI":"10.1038\/cddis.2014.337","article-title":"Release and activity of histone in diseases","volume":"5","author":"Chen","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jaut.2016.02.003_bib99","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/0961203308089990","article-title":"Apoptosis in the pathogenesis of systemic lupus erythematosus","volume":"17","author":"Munoz","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.02.003_bib100","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1756-185X.2009.01391.x","article-title":"Anti-nucleosome antibodies as a disease activity marker in patients with systemic lupus erythematosus","volume":"12","author":"Suleiman","year":"2009","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.02.003_bib101","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1053\/j.ajkd.2007.10.041","article-title":"Antinucleosome antibodies as a marker of active proliferative lupus nephritis","volume":"51","author":"Bigler","year":"2008","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jaut.2016.02.003_bib102","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/rheumatology\/keh024","article-title":"Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. potential utility as a diagnostic tool and disease activity marker","volume":"43","author":"Sim\u00f3n","year":"2004","journal-title":"Rheumatol. Oxf."},{"key":"10.1016\/j.jaut.2016.02.003_bib103","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jaut.2003.12.005","article-title":"Antinucleosome antibodies in SLE: a two-year follow-up study of 101 patients","volume":"22","author":"Ghirardello","year":"2004","journal-title":"J.\u00a0Autoimmun."},{"issue":"10","key":"10.1016\/j.jaut.2016.02.003_bib104","doi-asserted-by":"crossref","first-page":"e0140441","DOI":"10.1371\/journal.pone.0140441","article-title":"Co-positivity for anti-dsDNA, -nucleosome and -histone antibodies in lupus nephritis is indicative of high serum levels and severe ephropathy","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2016.02.003_bib105","first-page":"51","article-title":"Correlations between antinucleosome antibodies and anti-double-stranded DNA antibodies, C3, C4, and clinical activity in lupus patients","volume":"24","author":"Saisoong","year":"2006","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2016.02.003_bib106","first-page":"1538","article-title":"Diagnostic value of anti-nucleosome antibodies in the assessment of disease activity of systemic lupus erythematosus: a prospective study comparing anti-nucleosome with anti-dsDNA antibodies","volume":"33","author":"Guti\u00e9rrez-Adrianz\u00e9n","year":"2006","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.02.003_bib107","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/1529-0131(200001)43:1<76::AID-ANR10>3.0.CO;2-I","article-title":"Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus","volume":"43","author":"Amoura","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.02.003_bib108","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/rheumatology\/40.12.1405","article-title":"An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study","volume":"40","author":"Ravirajan","year":"2001","journal-title":"Rheumatol. Oxf."},{"key":"10.1016\/j.jaut.2016.02.003_bib109","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1196\/annals.1313.018","article-title":"The relevance of autoantigen source and cutoff definition in antichromatin (nucleosome) antibody immunoassays","volume":"1050","author":"Villalta","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2016.02.003_bib110","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1177\/0961203309345753","article-title":"Sensitivity and specificity of autoantibody tests in the differential diagnosis of lupus nephritis","volume":"18","author":"Heidenreich","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.02.003_bib111","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1191\/0961203302lu247oa","article-title":"The autoimmune response to chromatin antigens in systemic lupus erythematosus: autoantibodies against histone H1 are a highly specific marker for SLE associated with increased disease activity","volume":"11","author":"Schett","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.02.003_bib112","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.autrev.2012.07.002","article-title":"Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis","volume":"12","author":"Bizzaro","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2016.02.003_bib113","first-page":"61","article-title":"Diagnostic specificities and sensitivities of anti dsDNA, anti membrane DNA and anti nucleosomes autoantibodies","volume":"235","author":"Servais","year":"2001","journal-title":"Scand. J. Clin. Lab. Invest Suppl."},{"key":"10.1016\/j.jaut.2016.02.003_bib114","first-page":"387","article-title":"Detection of anti-nucleosome antibodies in a routine clinical laboratory setting","volume":"26","author":"Bossuyt","year":"2008","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2016.02.003_bib115","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/ard.2003.016303","article-title":"Anti-dsDNA antibodiwes and disease classification in antinuclear antibody positive patients: the role of analytical diversity","volume":"63","author":"Haugbro","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.02.003_bib116","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.autrev.2011.10.021","article-title":"Autoantibodies in lupus: culprits or passive bystanders?","volume":"11","author":"Rekvig","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2016.02.003_bib117","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00281-005-0007-y","article-title":"Antibodies against C1q in patients with systemic lupus erythematosus","volume":"27","author":"Trendelenburg","year":"2005","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.jaut.2016.02.003_bib118","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1093\/ndt\/gfl436","article-title":"High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis","volume":"21","author":"Trendelenburg","year":"2006","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.jaut.2016.02.003_bib119","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.autrev.2008.06.006","article-title":"Anti-C1q antibodies","volume":"7","author":"Kalleneberg","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2016.02.003_bib120","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/clin.1993.1066","article-title":"The relationship between serum titers of autoantibodies to C1q and age in the general population and in patients with systemic lupus erythematosus","volume":"67","author":"Siegert","year":"1993","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.jaut.2016.02.003_bib121","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/ard.52.12.851","article-title":"Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus","volume":"52","author":"Siegert","year":"1993","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.02.003_bib122","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0272-6386(95)90595-2","article-title":"Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus","volume":"26","author":"Coremans","year":"1995","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jaut.2016.02.003_bib123","first-page":"667","article-title":"High levels of antibodies against C1q are associated with disease activity and nephritis but not with other organ manifestations in SLE patients","volume":"19","author":"Horv\u00e1th","year":"2001","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2016.02.003_bib124","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/1529-0131(199901)42:1<187::AID-ANR24>3.0.CO;2-U","article-title":"Lack of occurrence of severe lupus nephritis among anti-C1q negative patients","volume":"42","author":"Tyndall","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.02.003_bib125","first-page":"1","article-title":"Anti-C1q antibody in patients with lupus nephritic flare: 18-month follow-up and a nested case-control study","volume":"10","author":"Fatemi","year":"2015","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jaut.2016.02.003_bib126","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1053\/ajkd.2001.22071","article-title":"Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis","volume":"37","author":"Moroni","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jaut.2016.02.003_bib127","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/ard.2006.065425","article-title":"A\u00a0prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine\/methylprednisolone","volume":"66","author":"Grootscholten","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.02.003_bib128","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/ard.2008.094508","article-title":"Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis","volume":"68","author":"Moroni","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.02.003_bib129","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/0961203314547791","article-title":"Anti-C1q antibodies in systemic lupus erythematosus","volume":"24","author":"Orbai","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.02.003_bib130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1749-6632.2009.04746.x","article-title":"Anti-C1q autoantibodies in lupus nephritis","volume":"1173","author":"Sinico","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2016.02.003_bib131","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/0961203310379871","article-title":"Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares","volume":"20","author":"Matrat","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.02.003_bib132","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/art.30401","article-title":"Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients","volume":"63","author":"Katsumata","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.02.003_bib133","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/ndt\/gfq558","article-title":"Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis","volume":"26","author":"Bigler","year":"2011","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.jaut.2016.02.003_bib134","doi-asserted-by":"crossref","first-page":"8225","DOI":"10.4049\/jimmunol.0902642","article-title":"Autoantibodies against C1q in systemic lupus erythematosus are antigen-driven","volume":"183","author":"Schaller","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib135","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.imlet.2012.08.007","article-title":"Biochemical analysis of the epitope specificities of anti-C1q autoantibodies accompanying human lupus nephritis reveals them as a dynamic population in the course of the disease","volume":"148","author":"Stoyanova","year":"2012","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jaut.2016.02.003_bib136","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nrrheum.2010.56","article-title":"Are anti-C1q antibodies different from other SLE autoantibodies?","volume":"6","author":"Pickering","year":"2010","journal-title":"Nat. Rev. Rheum."},{"key":"10.1016\/j.jaut.2016.02.003_bib137","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.4049\/jimmunol.0803573","article-title":"autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells","volume":"183","author":"Bigler","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib138","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1172\/JCI200421075","article-title":"Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes","volume":"114","author":"Trouw","year":"2004","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.jaut.2016.02.003_bib140","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1172\/JCI200422820","article-title":"Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus","volume":"114","author":"Holers","year":"2004","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.jaut.2016.02.003_bib141","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1078\/0171-2985-00141","article-title":"C1q, autoimmunity and apoptosis","volume":"205","author":"Botto","year":"2002","journal-title":"Immunobiology"},{"key":"10.1016\/j.jaut.2016.02.003_bib139","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-3083.2008.02089.x","article-title":"Complement component C1q and Anti-C1q antibodies in theory and in clinical practice","volume":"67","author":"Potlukova","year":"2008","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib142","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.imbio.2014.07.004","article-title":"Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in\u00a0vitro","volume":"219","author":"Pang","year":"2014","journal-title":"Immunobiology"},{"key":"10.1016\/j.jaut.2016.02.003_bib143","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.clim.2015.06.014","article-title":"Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways","volume":"160","author":"Thanei","year":"2015","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib144","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.molimm.2011.04.024","article-title":"Complement activation by (auto-) antibodies","volume":"48","author":"Daha","year":"2011","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib145","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/ndt\/gfn453","article-title":"Anti-C1q antibodies and IgG subclass distribution in sera from Chinese patients with lupus nephritis","volume":"24","author":"Fang","year":"2009","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.jaut.2016.02.003_bib146","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.molimm.2011.07.020","article-title":"Nucleosomes and C1q bound to glomerular endothelial cells serve as targets for autoantibodies and determine complement activation","volume":"49","author":"O'Flynn","year":"2011","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib147","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1586\/1744666X.2014.944162","article-title":"The role of dead cell clearance in the etiology and pathogenesis of systemic lupus erythematosus: dendritic cells as potential targets","volume":"10","author":"Biermann","year":"2014","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib148","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.4049\/jimmunol.158.10.4525","article-title":"C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and SLE revisited","volume":"158","author":"Korb","year":"1997","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib149","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaut.2013.06.002","article-title":"Anti-DNA antibodies cross-react with C1q","volume":"44","author":"Franchin","year":"2013","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2016.02.003_bib150","first-page":"1495","article-title":"Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus","volume":"30","author":"Mannik","year":"2003","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.02.003_bib151","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/j.15231755.2005.00503.x","article-title":"Podocyte involvement in human immune crescentic glomerulonephritis","volume":"68","author":"Bari\u00e9ty","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.jaut.2016.02.003_bib152","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1681\/ASN.2007121328","article-title":"Urine podocyte mRNAs mark progression of renal disease","volume":"20","author":"Sato","year":"2009","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.jaut.2016.02.003_bib153","first-page":"2185","article-title":"Expression patterns of podocyte-associated mRNAs in patients with proliferative or non-proliferative glomerulopathies","volume":"7","author":"Rodrigues","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.jaut.2016.02.003_bib154","first-page":"4600","article-title":"Podocyte-associated mRNA profiles in kidney tissue and in urine of patients with active lupus nephritis","volume":"8","author":"dos Santos","year":"2015","journal-title":"Int. J. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.jaut.2016.02.003_bib155","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S1568-9972(02)00028-9","article-title":"The targets of nephritogenic antibodies in systemic autoimmune disorders","volume":"1","author":"Migliorini","year":"2002","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.jaut.2016.02.003_bib156","first-page":"695","article-title":"Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with sistemic lupus erythematosus","volume":"33","author":"Mosca","year":"2006","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.02.003_bib157","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/ni1457","article-title":"Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE","volume":"8","author":"Tian","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib158","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1084\/jem.20052438","article-title":"TLR9\/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE","volume":"203","author":"Ehlers","year":"2006","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2016.02.003_bib159","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.4049\/jimmunol.178.4.2415","article-title":"TLR9 signaling in B cells determines class switch recombination to IgG2a","volume":"178","author":"Jegerlehner","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib160","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1084\/jem.20050338","article-title":"Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus","volume":"202","author":"Christensen","year":"2005","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2016.02.003_bib161","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.4049\/jimmunol.169.7.4046","article-title":"Orderly pattern of development of the autoantibody response in NZB\/NZW F1 mice: characterization of target antigens and antigen spreading by two-dimensional gel electrophoresis and mass spectrometry","volume":"169","author":"Th\u00e9bault","year":"2002","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib162","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1177\/0961203312462267","article-title":"Nephritogenic-antinephritogenic antibody network in lupus glomerulonephritis","volume":"21","author":"Doria","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.02.003_bib163","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.autrev.2014.10.003","article-title":"A\u00a0volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients","volume":"14","author":"Yaniv","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2016.02.003_bib164","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1399-0039.2011.01645.x","article-title":"The long pentraxin PTX3 at the crossroads between innate immunity and tissue remodelling","volume":"77","author":"Inforzato","year":"2011","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaut.2016.02.003_bib165","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/08916934.2011.611549","article-title":"Long pentraxin 3 (PTX3) in the light of its structure, mechanism of action and clinical implications","volume":"45","author":"Cie\u015blik","year":"2012","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2016.02.003_bib166","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3389\/fimmu.2012.00378","article-title":"Host-protective effect of circulating pentraxin 3 (PTX3) and complex formation with neutrophil extracellular traps","volume":"3","author":"Daigo","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib167","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature01195","article-title":"Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response","volume":"420","author":"Garlanda","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2016.02.003_bib168","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1182\/blood.V96.13.4300","article-title":"The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells","volume":"96","author":"Rovere","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2016.02.003_bib169","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/immu.200310022","article-title":"Biochemical and functional characterization of the interaction between pentraxin 3 and C1q","volume":"33","author":"Nauta","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib170","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1189\/jlb.0805445","article-title":"The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells","volume":"80","author":"Baruah","year":"2006","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.jaut.2016.02.003_bib171","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/ard.2009.117804","article-title":"IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus","volume":"69","author":"Bassi","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.02.003_bib172","doi-asserted-by":"crossref","DOI":"10.1007\/s12016-015-8476-9","article-title":"PTX3, anti-PTX3, and anti-C1q autoantibodies in lupus glomerulonephritis","volume":"49","author":"Bassi","year":"2015","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib173","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.clim.2012.01.002","article-title":"IgM autoantibodies to distinct apoptosis-associated antigens correlate with protection from cardiovascular events and renal disease in patients with SLE","volume":"142","author":"Groenwall","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib174","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s002960050063","article-title":"IgM anti-dsDNA antibodies in systemic lupus erythematosus: negative association with nephritis","volume":"18","author":"Witte","year":"1998","journal-title":"SLE Study Group Rheumatol. Int."},{"key":"10.1016\/j.jaut.2016.02.003_bib175","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1191\/0961203304lu485oa","article-title":"Clinical significance of anti-dsDNA antibody isotypes: IgG\/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis","volume":"13","author":"Forger","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.02.003_bib176","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1568-9972(03)00081-8","article-title":"Anti-DNA antibody subpopulations and lupus nephritis","volume":"3","author":"Rekvig","year":"2004","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2016.02.003_bib177","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.molimm.2013.04.004","article-title":"The constant region affects antigen binding of antibodies to DNA by altering secondary structure","volume":"56","author":"Xia","year":"2013","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib178","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jaut.2012.06.005","article-title":"The constant region contributes to the antigenic specificity and renal pathogenicity of murine anti-DNA antibodies","volume":"39","author":"Xia","year":"2012","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2016.02.003_bib179","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071458","article-title":"Anti-dsDNA antibody isotypes in systemic lupus erythematosus:IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease","volume":"8","author":"Villalta","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2016.02.003_bib180","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s12016-007-8046-x","article-title":"IgM Antibodies Against dsDNA in SLE","volume":"34","author":"Witte","year":"2008","journal-title":"Clin. Rev. Allerg. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib181","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1874312901307010101","article-title":"Concomitance of IgM and IgG anti-dsDNA antibodies does not appear to associate to active Lupus nephritis","volume":"7","author":"Keiserman","year":"2013","journal-title":"Open Rheumatol. J."},{"key":"10.1016\/j.jaut.2016.02.003_bib182","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1002\/art.21379","article-title":"Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse","volume":"52","author":"Werwitzke","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.02.003_bib183","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1002\/art.21252","article-title":"Protective autoantibodies: role in homeostasis, clinical importance, and therapeutic potential","volume":"52","author":"Shoenfeld","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.02.003_bib184","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1084\/jem.20031942","article-title":"Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes","volume":"199","author":"Boule","year":"2004","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2016.02.003_bib185","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3899\/jrheum.140796","article-title":"Anti-dsDNA and Antichromatin Antibody Isotypes in serologically active clinically quiescent systemic lupus erythematosus","volume":"42","author":"Steiman","year":"2015","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2016.02.003_bib186","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008474","article-title":"Anti-dsDNA antibodies promote initiation, and acquired loss of renal Dnase1 promotes progression of lupus nephritis in autoimmune (NZBxNZW)F1 mice","volume":"4","author":"Fenton","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2016.02.003_bib187","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/08916930802375729","article-title":"Exposure of chromatin and not high affinity for dsDNA determines the nephritogenic impact of anti-dsDNA antibodies in (NZBxNZW)F1 mice","volume":"42","author":"Mjelle","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2016.02.003_bib188","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/08830188909086990","article-title":"Pathogenic subsets of antibodies to DNA","volume":"5","author":"Ebling","year":"1989","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.jaut.2016.02.003_bib189","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1093\/ndt\/gfm194","article-title":"Expression of glomerular heparin sulphate domains in murine and human lupus nephritis","volume":"22","author":"Rops","year":"2007","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.jaut.2016.02.003_bib190","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/art.38250","article-title":"Pathogenic mechanisms in lupus nephritis: nucleosomes bind aberrant laminin \u03b21 with high affinity and colocalize in the electron-dense deposits","volume":"66","author":"Olin","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2016.02.003_bib191","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2353\/ajpath.2009.080943","article-title":"Progression of murine lupus nephritis is linked to acquired renal DNase1 deficiency and not to up-regulated apoptosis","volume":"175","author":"Seredkina","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2016.02.003_bib192","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.ajpath.2011.05.011","article-title":"Acquired loss of renal nuclease activity is restricted to DNaseI and is an organ-selective feature in murine lupus nephritis","volume":"179","author":"Seredkina","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2016.02.003_bib193","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0076-6879(08)01414-6","article-title":"Nucleases in programmed cell death","volume":"442","author":"Kawane","year":"2008","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jaut.2016.02.003_bib194","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.cyto.2013.03.016","article-title":"Nucleosomes contribute to increase mesangial cell chemokine expression during the development of lupus nephritis","volume":"62","author":"Kanapathippillai","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.jaut.2016.02.003_bib195","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/ar3281","article-title":"Chromatin as a target antigen in human and murine lupus nephritis","volume":"13","author":"Hedberg","year":"2011","journal-title":"Arthritis Res. Ther."},{"issue":"8","key":"10.1016\/j.jaut.2016.02.003_bib196","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012096","article-title":"Renal Dnase1 enzyme activity and protein expression is selectively shut down in murine and human membranoproliferative lupus nephritis","volume":"5","author":"Zykova","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2016.02.003_bib197","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.molcel.2012.08.027","article-title":"RNA polymerase II collision interrupts convergent transcription","volume":"48","author":"Hobson","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jaut.2016.02.003_bib198","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ajpath.2012.11.013","article-title":"Impact of the tumor necrosis factor receptor-associated protein 1 (Trap1) on renal DNaseI shutdown and on progression of murine and human lupus nephritis","volume":"182","author":"Fismen","year":"2012","journal-title":"Am. J. Pathol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841116300051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841116300051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:13:44Z","timestamp":1760256824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841116300051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":198,"alternative-id":["S0896841116300051"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2016.02.003","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and pathologic considerations of the qualitative and quantitative aspects of lupus nephritogenic autoantibodies: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2016.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}